Medical device makers faced a productive but challenging year in 2011. They innovated existing lines, launched new devices and invested in R&D. But they also experienced funding cutbacks and new taxes and regulations. In this report, The Global Market for Medical Devices, 3rd. Edition, Kalorama Information analyzes the current device market in the United States, Europe, Asia and globally, profiles the key players and discusses trends important for market watchers to know.
The medical device market is vast -- everything from a large imaging system to a disposable item can be classified as a type of medical device -- but also provides opportunity for new entrants. While in dollar terms the pharmaceutical market is greater, the device market has more participants and is responsible for more orders and transactions. Throughout the past decade, Kalorama Information has covered many device markets in detail. Certain areas such as infusion pumps, patient monitoring and catheters have shown promising growth. Others have solid market leaders earning stable revenue.
What are the fastest-growing markets for medical devices? Who are the main participants and what competitive moves did they make in 2011? How have device companies fared in a weaker-than-expected recovery? What impact will US healthcare reform and its new taxes have on the industry in the largest medical device market? How much of the business has shifted out of the US?
This Kalorama Information report answers these questions and examines the global medical device industry and the key competitors participating in it. Combining the expert knowledge of Kalorama Information's reporting on device markets and analysis of 2010 results, the report provides insights into current trends that will be of interest to anyone watching the medical device market. As part of its coverage, the report includes:
All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.
For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog
Related Reports:The World Market for Flow Cytometry in IVD Applications
Jun 16, 2014 - KLI5271977 - $1,995.00
Advanced Wound Care Markets Worldwide (Skin Ulcers, Burns, Surgical and Trauma, Moist Dressings, Negative Pressure, Biological Dressings, Anti-Infectives, Staples, Sutures, Cleansing, Debridement, Tapes, Other Devices)
Jun 11, 2014 - KLI5268759 - $4,500.00
The Global Market for Medical Devices, 5th Edition
May 28, 2014 - KLI5254463 - $2,500.00
Medical Device Markets in The Middle East
May 14, 2014 - KLI5241892 - $995.00
Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments
May 7, 2014 - KLI5239832 - $4,500.00
Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)
Apr 21, 2014 - KLI5232511 - $3,995.00
EMR 2014: The Market for Electronic Medical Records
Apr 2, 2014 - KLI5225054 - $3,995.00
The United States Market for In Vitro Diagnostic Tests
Mar 18, 2014 - KLI5217921 - $3,995.00
Retail Clinics Market Overview and 2014 Survey Results
Mar 11, 2014 - KLI5215143 - $750.00
Surgical Procedure Volumes: Global Analysis (US, China, Japan, Brazil, UK, Germany, Italy, France, Mexico, Russia)
Feb 22, 2014 - KLI5205473 - $2,995.00
Questions?Contact a research specialist >
Most Popular ResearchResults of The 2012 Kalorama IVD Procedure Count: White Paper The World Market for Point of Care (POC) Diagnostics World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) Why Epigenomics May Be a Game-Changer in Diagnostics and Pharmaceuticals IVD Procedure Volume and Pricing Analysis White Paper: The Molecular Era in IVD Testing